tiprankstipranks
Sight Sciences does BIA of TearCare to treat MGD-associated DED in US
PremiumThe FlySight Sciences does BIA of TearCare to treat MGD-associated DED in US
1M ago
Sight Sciences price target lowered to $4.60 from $5.80 at Citi
Premium
The Fly
Sight Sciences price target lowered to $4.60 from $5.80 at Citi
2M ago
Sight Sciences initiated with a Buy at UBS
Premium
The Fly
Sight Sciences initiated with a Buy at UBS
2M ago
Sight Sciences backs FY24 revenue view, sees operating expenses down 4%-6%
PremiumThe FlySight Sciences backs FY24 revenue view, sees operating expenses down 4%-6%
3M ago
Sight Sciences reports Q3 EPS (22c), consensus (21c)
Premium
The Fly
Sight Sciences reports Q3 EPS (22c), consensus (21c)
3M ago
Sight Sciences Reports Revenue Growth and Leadership Change
Premium
Company Announcements
Sight Sciences Reports Revenue Growth and Leadership Change
3M ago
Sight Sciences initiated with a Buy at Lake Street
PremiumThe FlySight Sciences initiated with a Buy at Lake Street
5M ago
Sight Sciences Unveils Investor Presentation for Future Talks
Premium
Company Announcements
Sight Sciences Unveils Investor Presentation for Future Talks
6M ago
Sight Sciences narrows FY24 revenue view to $81M to $83M,consensus $83.83M
Premium
The Fly
Sight Sciences narrows FY24 revenue view to $81M to $83M,consensus $83.83M
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100